We’re thrilled to be back in person in Lisbon! Whether you need to intensify your upstream bioprocesses or scale up your gene therapy production, we have great workshops and posters for you.

Join us at booth 60 to chat and learn about our latest solutions. Want to schedule a meeting?

Click here to book time with one of our experts. 

Featured symposium - From research to clinic: Modern approaches to biopharma commercialization

26 June, 14:30 – 16:00

Establishing a CHO K1 cell line platform suitable for biotherapeutic production

Paula Ravnikar PhD, Global Technical Manager, Cytiva

Advances in the development of continuous biopharma production processes

Véronique Chotteau, PhD, Assoc. Prof., Director of AdBIOPRO

Key success factors for the successful scaling of bioreactor processes

TBC

Scaling strategies for gene therapy processes with recombinant adeno-associated virus (rAAV) from lab to production scale

Artur Padzik, PhD, AAV production manager, Biovian

Featured posters

Process development for rAAV production using Design of Experiment model

Ann-Christin Magnusson, Staff Research Engineer, Cytiva

Scalable production of rAAV in different single-use bioreactor platforms

Ann-Christin Magnusson, Staff Research Engineer, Cytiva

Cell culture applications of HyClone™ Classical Media and HyClone™ Serum

Ann Lövgren, Principal Scientist, Cytiva

Development of HEK293 transfection media prototype for transient recombinant protein expression and gene therapy applications

Caroline Tsao, Lead Scientist, Cytiva

Quantitative assessment of desirability of platform cell culture media - ESACT TOP100 poster!

Kimberly Curtis, Lead Scientist, Cytiva

Generating a robust host cell line, GOCHO™, for Cytiva’s cell line development platform

Michelle Sabourin, Senior Scientist, Cytiva

Establishing a robust workflow to identify high performing GOCHO™ clones

Sheffali Dash, Senior Scientist, Cytiva

Bioreactor scaling made easy: navigating the design space

Andreas Castan, Strategic Technology Partnerships Leader, Cytiva

Direct adaptations of BHK into serum-free growth

Ann Lövgren, Principal Scientist, Cytiva

Intensification of fed batch using N-1 perfusion

Saana Tronnersjö, Senior Scientist, Cytiva

Computational simulation as a predictive tool for bioreactor design and performance

Andreas Castan, Strategic Technology Partnerships Leader, Cytiva

A novel, targeted integration platform for evaluation of vector elements in CHO cells

Ann Lövgren, Principal Scientist, Cytiva

More resources

Upstream bioprocessing

Support for cell culture media and upstream process development plus pilot-scale

Learn more 

Cell and gene therapy

Improving a single process step or designing a platform to treat thousands

Learn more